Mink Therapeutics (INKT) shares were 69% higher pre-bell Tuesday after the company said it has entered into a strategic partnership with C-Further to develop a cell therapy for pediatric cancers.
Zevra Therapeutics (ZVRA) stock was up 15%, a day after the company reported improved Q4 financial results.
Teladoc Health (TDOC) shares were 8% higher after Deutsche Bank (DB) upgraded the company's stock to buy from hold.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments